Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1414

1.

The use of infrared thermography in the measurement and characterization of brown adipose tissue activation.

Law J, Chalmers J, Morris DE, Robinson L, Budge H, Symonds ME.

Temperature (Austin). 2018 Jan 29;5(2):147-161. doi: 10.1080/23328940.2017.1397085. eCollection 2018. Review.

PMID:
30393752
2.

Palmitate induces an anti-inflammatory response in immortalized microglial BV-2 and IMG cell lines that decreases TNFα levels in mHypoE-46 hypothalamic neurons in co-culture.

Kim S, McIlwraith E, Chalmers J, Belsham D.

Neuroendocrinology. 2018 Oct 23. doi: 10.1159/000494759. [Epub ahead of print]

PMID:
30352432
3.

How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis.

Terranova L, Oriano M, Teri A, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Contarini M, Franceschi E, Sottotetti S, Cariani L, Bevivino A, Chalmers JD, Aliberti S, Blasi F.

Int J Mol Sci. 2018 Oct 20;19(10). pii: E3256. doi: 10.3390/ijms19103256.

4.

Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy.

Anderson CS, Woodward M, Arima H, Chen X, Lindley RI, Wang X, Chalmers J, Robinson TG.

Int J Stroke. 2018 Oct 9:1747493018806170. doi: 10.1177/1747493018806170. [Epub ahead of print]

PMID:
30299230
5.

NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke.

Yoshimura S, Lindley RI, Carcel C, Sato S, Delcourt C, Wang X, Chalmers J, Anderson CS; ENCHANTED Investigators.

Neurology. 2018 Oct 30;91(18):e1695-e1701. doi: 10.1212/WNL.0000000000006437. Epub 2018 Sep 28.

PMID:
30266885
6.

Distinct 'Immuno-Allertypes' of Disease and High Frequencies of Sensitisation in Non-Cystic-Fibrosis Bronchiectasis.

Mac Aogáin M, Tiew PY, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Ong TC, Tiong YS, Wong KN, Narayanan S, Bijin Au V, Marlier D, Keir HR, Tee A, Abisheganaden JA, Koh MS, Wang Y, Connolly JE, Chew FT, Chalmers JD, Chotirmall SH.

Am J Respir Crit Care Med. 2018 Sep 28. doi: 10.1164/rccm.201807-1355OC. [Epub ahead of print]

PMID:
30265843
7.

A systematic review of clinical trial registration in major respiratory journals 2010-2018.

Suntila NS, Smith A, Al-Dabbagh Y, Chalmers JD.

Eur Respir J. 2018 Sep 27. pii: 1801491. doi: 10.1183/13993003.01491-2018. [Epub ahead of print] No abstract available.

PMID:
30262578
8.

Control of Confounding and Reporting of Results in Causal Inference Studies: Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.

Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay E, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL.

Ann Am Thorac Soc. 2018 Sep 19. doi: 10.1513/AnnalsATS.201808-564PS. [Epub ahead of print] No abstract available.

PMID:
30230362
9.

Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Flume PA, Chalmers JD, Olivier KN.

Lancet. 2018 Sep 8;392(10150):880-890. doi: 10.1016/S0140-6736(18)31767-7. Review.

PMID:
30215383
10.

The future of accreditation of continuing medical education (CME)-continuing professional development (CPD) in Europe: harmonisation through dialogue and consensus.

de Andrade F, Griebenow R, Costello RW, Guenova M, Schaefer R, Chalmers JD, Tichelli A, Raguz D, Stein J.

J Eur CME. 2018 Sep 3;7(1):1506202. doi: 10.1080/21614083.2018.1506202. eCollection 2018.

11.

Treatable traits in bronchiectasis.

Boaventura R, Sibila O, Agusti A, Chalmers JD.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801269. doi: 10.1183/13993003.01269-2018. Print 2018 Sep. No abstract available.

PMID:
30190263
12.

Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention.

Mundra PA, Barlow CK, Nestel PJ, Barnes EH, Kirby A, Thompson P, Sullivan DR, Alshehry ZH, Mellett NA, Huynh K, Jayawardana KS, Giles C, McConville MJ, Zoungas S, Hillis GS, Chalmers J, Woodward M, Wong G, Kingwell BA, Simes J, Tonkin AM, Meikle PJ; LIPID Study Investigators.

JCI Insight. 2018 Sep 6;3(17). pii: 121326. doi: 10.1172/jci.insight.121326. [Epub ahead of print]

13.

Psychosocial Assessment Using Telehealth in Adolescents and Young Adults With Cancer: A Partially Randomized Patient Preference Pilot Study.

Chalmers JA, Sansom-Daly UM, Patterson P, McCowage G, Anazodo A.

JMIR Res Protoc. 2018 Aug 29;7(8):e168. doi: 10.2196/resprot.8886.

14.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

15.

Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference.

Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):28. doi: 10.1186/s40248-018-0138-3. eCollection 2018. No abstract available.

16.

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Contarini M, Shoemark A, Rademacher J, Finch S, Gramegna A, Gaffuri M, Roncoroni L, Seia M, Ringshausen FC, Welte T, Blasi F, Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):26. doi: 10.1186/s40248-018-0143-6. eCollection 2018. Review.

17.

Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial.

Santo K, Singleton A, Rogers K, Thiagalingam A, Chalmers J, Chow CK, Redfern J.

Heart. 2018 Aug 27. pii: heartjnl-2018-313479. doi: 10.1136/heartjnl-2018-313479. [Epub ahead of print]

PMID:
30150326
18.

Towards a better understanding of outcome measurement instruments for atopic eczema.

Chalmers JR, Danby S.

Br J Dermatol. 2018 Aug;179(2):246-247. doi: 10.1111/bjd.16827. No abstract available.

PMID:
30141558
19.

A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.

McDonnell MJ, O'Toole D, Ward C, Pearson JP, Lordan JL, De Soyza A, Loebinger M, Chalmers JD, Laffey JG, Rutherford RM.

Respir Med. 2018 Aug;141:132-143. doi: 10.1016/j.rmed.2018.06.031. Epub 2018 Jun 30. Review.

PMID:
30053958
20.

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800328. doi: 10.1183/13993003.00328-2018. Print 2018 Sep. Review.

PMID:
30049739
21.

Bronchiectasis: a case-based approach to investigation and management.

Contarini M, Finch S, Chalmers JD.

Eur Respir Rev. 2018 Jul 11;27(149). pii: 180016. doi: 10.1183/16000617.0016-2018. Print 2018 Sep 30. Review.

22.

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients.

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S; GLIMP.

Eur Respir J. 2018 Aug 9;52(2). pii: 1701190. doi: 10.1183/13993003.01190-2017. Print 2018 Aug.

PMID:
29976651
23.

Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.

Thomas MC, Woodward M, Li Q, Pickering R, Tikellis C, Poulter N, Cooper ME, Marre M, Zoungas S, Chalmers J; ADVANCE Collaborative Group.

J Am Heart Assoc. 2018 Jun 30;7(13). pii: e008226. doi: 10.1161/JAHA.117.008226.

24.

The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis.

Goeminne PC, Cox B, Finch S, Loebinger MR, Bedi P, Hill AT, Fardon TC, de Hoogh K, Nawrot TS, Chalmers JD.

Eur Respir J. 2018 Jul 27;52(1). pii: 1702557. doi: 10.1183/13993003.02557-2017. Print 2018 Jul.

PMID:
29903857
25.

Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study.

Mac Aogáin M, Chandrasekaran R, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Hui Qi Ng A, Bertrand D, Koh JY, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Chew FT, Keir HR, Connolly JE, Abisheganaden JA, Koh MS, Nagarajan N, Chalmers JD, Chotirmall SH.

Eur Respir J. 2018 Jul 27;52(1). pii: 1800766. doi: 10.1183/13993003.00766-2018. Print 2018 Jul.

26.

Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry.

Liu NM, van Aalderen W, Carlsen KCL, Coleman C, Chalmers JD, Cunningham S, Fernandes RM, Fleming LJ, Gappa M, Karadag B, Midulla F, Pijnenburg MWH, Rutjes NW, Rusconi F, Grigg J.

Breathe (Sheff). 2018 Jun;14(2):93-98. doi: 10.1183/20734735.002018. Review.

27.

Occupational heat exposure among municipal workers.

Uejio CK, Morano LH, Jung J, Kintziger K, Jagger M, Chalmers J, Holmes T.

Int Arch Occup Environ Health. 2018 Aug;91(6):705-715. doi: 10.1007/s00420-018-1318-3. Epub 2018 Jun 5.

PMID:
29869703
28.

Continuous versus intermittent antibiotics for bronchiectasis.

Donovan T, Felix LM, Chalmers JD, Milan SJ, Mathioudakis AG, Spencer S.

Cochrane Database Syst Rev. 2018 Jun 3;6:CD012733. doi: 10.1002/14651858.CD012733.pub2. Review.

PMID:
29860722
29.

The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study.

Santo K, Hyun K, de Keizer L, Thiagalingam A, Hillis GS, Chalmers J, Redfern J, Chow CK.

Int J Behav Nutr Phys Act. 2018 May 23;15(1):45. doi: 10.1186/s12966-018-0677-1.

30.

"The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study.

Dudgeon EK, Crichton M, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):81. doi: 10.1186/s12890-018-0631-7.

31.

Bronchiectasis: an emerging global epidemic.

Chotirmall SH, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):76. doi: 10.1186/s12890-018-0629-1.

32.

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Chandrasekaran R, Mac Aogáin M, Chalmers JD, Elborn SJ, Chotirmall SH.

BMC Pulm Med. 2018 May 22;18(1):83. doi: 10.1186/s12890-018-0638-0. Review.

33.

Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database.

Nagel S, Wang X, Carcel C, Robinson T, Lindley RI, Chalmers J, Anderson CS; ENCHANTED Investigators.

Stroke. 2018 Jun;49(6):1407-1411. doi: 10.1161/STROKEAHA.117.019863. Epub 2018 May 18.

PMID:
29777016
34.

Predicting outcomes in bronchiectasis.

Mendes MA, Chalmers JD.

Pulmonology. 2018 May - Jun;24(3):146-148. doi: 10.1016/j.pulmoe.2018.04.004. No abstract available.

35.

Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative.

Grinich EE, Schmitt J, Küster D, Spuls PI, Williams HC, Chalmers JR, Thomas KS, Apfelbacher C, Prinsen CAC, Furue M, Stuart B, Carter B, Simpson EL.

Br J Dermatol. 2018 Aug;179(2):540-541. doi: 10.1111/bjd.16732. Epub 2018 Jun 25. No abstract available.

PMID:
29747242
36.

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.

Welsh P, Rankin N, Li Q, Mark PB, Würtz P, Ala-Korpela M, Marre M, Poulter N, Hamet P, Chalmers J, Woodward M, Sattar N.

Diabetologia. 2018 Jul;61(7):1581-1591. doi: 10.1007/s00125-018-4619-x. Epub 2018 May 4.

37.

Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.

Minhas JS, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Donnan GA, Kim JS, Lavados PM, Lee TH, Martins SCO, Olavarría VV, Pandian JD, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Thang NH, Wang JG, Woodward M, Chalmers J, Anderson CS, Robinson TG; ENCHANTED Investigators.

Cerebrovasc Dis. 2018;45(5-6):213-220. doi: 10.1159/000488911. Epub 2018 Apr 27.

PMID:
29705803
38.

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Thomas KS, Apfelbacher C, Williams HC, Prinsen CA, Spuls PI, Simpson E, Gerbens LAA, Boers M, Barbarot S, Stalder JF, Abuabara K, Aoki V, Ardeleanu M, Armstrong J, Bang B, Berents TL, Burton T, Butler L, Chubachi T, Cresswell-Melville A, DeLozier A, Eckert L, Eichenfield L, Flohr C, Futamura M, Gadkari A, Gjerde ES, van Halewijn KF, Hawkes C, Howells L, Howie L, Humphreys R, Ishii HA, Kataoka Y, Katayama I, Kouwenhoven W, Langan SM, Leshem YA, Merhand S, Mina-Osorio P, Murota H, Nakahara T, Nunes FP, Nygaard U, Nygårdas M, Ohya Y, Ono E, Rehbinder E, Rogers NK, Romeijn GLE, Schuttelaar MLA, Sears AV, Simpson MA, Singh JA, Srour J, Stuart B, Svensson Å, Talmo G, Talmo H, Teixeira HD, Thyssen JP, Todd G, Torchet F, Volke A, von Kobyletzki L, Weisshaar E, Wollenberg A, Zaniboni M.

Br J Dermatol. 2018 May;178(5):e332-e341. doi: 10.1111/bjd.16543. Epub 2018 Apr 19.

PMID:
29672835
40.

More on Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.

Anderson CS, Woodward M, Chalmers J.

N Engl J Med. 2018 Apr 12;378(15):1465-1466. doi: 10.1056/NEJMc1801548. No abstract available.

41.

Insulin-like growth factor-binding protein-4 inhibits epithelial growth and proliferation in the rodent intestine.

Austin K, Tsang D, Chalmers JA, Maalouf MF, Brubaker PL.

Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G206-G219. doi: 10.1152/ajpgi.00349.2017. Epub 2018 Apr 6.

PMID:
29631376
42.

Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial.

Haines RH, Thomas KS, Montgomery AA, Ravenscroft JC, Akram P, Chalmers JR, Whitham D, Duley L, Eleftheriadou V, Meakin G, Mitchell EJ, White J, Rogers A, Sach T, Santer M, Tan W, Hepburn T, Williams HC, Batchelor J.

BMJ Open. 2018 Apr 3;8(4):e018649. doi: 10.1136/bmjopen-2017-018649.

43.

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.

Torres A, Cillóniz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, Schmitt HJ, Welte T.

Respir Med. 2018 Apr;137:6-13. doi: 10.1016/j.rmed.2018.02.007. Epub 2018 Feb 19. Review.

PMID:
29605214
44.

Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.

Rådholm K, Chalmers J, Ohkuma T, Peters S, Poulter N, Hamet P, Harrap S, Woodward M.

Diabetes Obes Metab. 2018 Aug;20(8):1903-1910. doi: 10.1111/dom.13311. Epub 2018 May 6.

PMID:
29603537
45.

Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges.

Lustberg MB, Stover DG, Chalmers JJ.

Cancer J. 2018 Mar/Apr;24(2):61-64. doi: 10.1097/PPO.0000000000000309.

PMID:
29601331
46.

Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.

Wang X, You S, Sato S, Yang J, Carcel C, Zheng D, Yoshimura S, Anderson CS, Sandset EC, Robinson T, Chalmers J, Sharma VK.

Stroke Vasc Neurol. 2018 Jan 13;3(1):28-33. doi: 10.1136/svn-2017-000112. eCollection 2018 Mar.

47.

Correction: Clinical applications of infrared and Raman spectroscopy: state of play and future challenges.

Baker MJ, Byrne HJ, Chalmers J, Gardner P, Goodacre R, Henderson A, Kazarian SG, Martin FL, Moger J, Stone N, Sulé-Suso J.

Analyst. 2018 Apr 16;143(8):1934. doi: 10.1039/c8an90029a.

PMID:
29595198
48.

Oral versus inhaled antibiotics for bronchiectasis.

Spencer S, Felix LM, Milan SJ, Normansell R, Goeminne PC, Chalmers JD, Donovan T.

Cochrane Database Syst Rev. 2018 Mar 27;3:CD012579. doi: 10.1002/14651858.CD012579.pub2. Review.

PMID:
29587336
49.

Pharmacy informatics in multihospital health systems: Opportunities and challenges.

Chalmers J, Siska M, Le T, Knoer S.

Am J Health Syst Pharm. 2018 Apr 1;75(7):457-464. doi: 10.2146/ajhp170580.

PMID:
29572314
50.

Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.

Chen G, Wang X, Robinson TG, Pikkemaat M, Lindley RI, Zhou S, Ping L, Liu W, Liu L, Chalmers J, Anderson CS; ENCHANTED Investigators.

J Neurol Sci. 2018 Apr 15;387:1-5. doi: 10.1016/j.jns.2018.01.014. Epub 2018 Jan 11.

PMID:
29571842

Supplemental Content

Loading ...
Support Center